JPMORGAN CHASE & CO - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$1,0007,434
+292.7%
0.00%
Q3 2018$0
-100.0%
1,893
+89.3%
0.00%
Q2 2018$1,000
-100.0%
1,000
-99.9%
0.00%
Q1 2018$2,309,000
+2750.6%
991,184
+3392.4%
0.00%
Q4 2017$81,000
-95.9%
28,381
-94.9%
0.00%
Q1 2017$1,994,000
-10.9%
552,166
-12.6%
0.00%
-100.0%
Q4 2016$2,237,000
-8.2%
631,900
+4.7%
0.00%0.0%
Q3 2016$2,438,000
-12.2%
603,700
-4.6%
0.00%0.0%
Q2 2016$2,776,000
+6.4%
632,520
-8.3%
0.00%0.0%
Q1 2016$2,608,000
-53.0%
690,128
+94.9%
0.00%0.0%
Q4 2015$5,553,000
+67.2%
354,079
+12.4%
0.00%0.0%
Q3 2015$3,321,000
-53.5%
315,099
+11.4%
0.00%
-50.0%
Q2 2015$7,135,000
-28.0%
282,898
-20.4%
0.00%0.0%
Q1 2015$9,906,000
+32.9%
355,457
-13.0%
0.00%0.0%
Q4 2014$7,454,000
+17.2%
408,483
-16.8%
0.00%0.0%
Q3 2014$6,362,000
-22.2%
490,771
-2.1%
0.00%0.0%
Q2 2014$8,182,000
+166.3%
501,384
+188.4%
0.00%
+100.0%
Q1 2014$3,072,000
-26.3%
173,857
+1.0%
0.00%0.0%
Q4 2013$4,168,000
-60.0%
172,128
-41.5%
0.00%
-66.7%
Q3 2013$10,422,000
+99.5%
294,134
-12.1%
0.00%
+50.0%
Q2 2013$5,225,000334,7400.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2015
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders